Global Home Infusion Therapy Market to Grow at a CAGR of 5.3% During 2024-2032, Driven by Rising Demand for Outpatient Care

The home infusion therapy market size is experiencing robust growth, driven by factors that reflect the changing dynamics of healthcare delivery and patient preferences. Key among these drivers is the increasing prevalence of chronic diseases worldwide, such as diabetes, cancer, and cardiovascular disorders, which require long-term and often complex treatment regimens. This trend is coupled with a growing elderly population, which is more susceptible to such conditions and demonstrates a preference for receiving care in the comfort of their homes.

In October 2023 , Horizon Blue Cross Blue Shield of New Jersey (a company that provides health insurance products), in collaboration with RWJBarnabas Health and Rutgers Cancer Institute of New Jersey (CINJ), launched a pioneering oncology home infusion program that has seen over 160 patients participate since its inception in late 2020. Highlighted at the AMCP Nexus 2023, the program aims to transition cancer treatment from traditional hospital settings to the comfort of patients' homes, enhancing convenience and reducing costs.

 
With high patient satisfaction reported, the program includes a growing list of 30 drugs, such as trastuzumab (Herceptin) and bevacizumab (Avastin), though PD-1 inhibitors like Keytruda (pembrolizumab) are currently excluded due to the complexity of combination therapies. Horizon's initiative represents a significant shift in managed care, emphasizing patient-centric approaches in oncology treatment and exploring expansion opportunities with other providers.

The desire for cost-effective healthcare solutions is another critical factor propelling the home infusion therapy market demand. Home-based care is often less expensive than inpatient treatment, offering savings for both healthcare systems and patients. This cost-effectiveness, combined with the enhanced patient quality of life and convenience associated with receiving treatment at home, has encouraged both payers and providers to support the shift towards home infusion therapy.

In May 2023 , Option Care Health announced a USD 3.6 billion all-stock deal to acquire Amedisys Inc., a leading home health and hospice provider. This merger, combining financial prowess with a combined 2022 revenue of about USD 6.2 billion and adjusted EBITDA nearing USD 622 billion, will create a powerhouse in the home infusion and alternate-site care market. With a workforce of 16,500 and operations across 674 locations in 46 states, the merged entity aims to address the growing demand for at-home healthcare services.

The deal, expected to close in the second half of the year, will see Amedisys stockholders owning approximately 35.5% of the combined company. This strategic merger is poised to capitalize on the increasing preference among payers and health systems for comprehensive home health services, promising significant market share growth and improved patient care delivery.

Technological advancements in infusion pumps, monitoring systems, and other related medical devices have significantly contributed to the market's expansion. These innovations have made it possible to safely and effectively administer a wide range of therapies, including antibiotics, antifungals, nutrition, hydration, and chemotherapy, outside the traditional hospital setting. Additionally, improvements in telehealth and remote monitoring technologies have further facilitated the adoption of home infusion therapy by ensuring continuous clinical oversight without the need for physical presence.

Government initiatives and regulatory support for home healthcare services across various countries have also played a pivotal role in promoting the use of home infusion therapy. These policies aim to reduce hospital readmission rates, lower the burden on healthcare facilities, and improve patient outcomes by encouraging treatments that can be effectively managed at home.

Despite the positive growth trajectory, the market faces challenges, including the need for comprehensive patient education, the establishment of robust home care protocols, and the availability of skilled healthcare professionals to manage home infusion therapies. However, the ongoing advancements in healthcare technologies, coupled with the increasing collaboration between healthcare providers, payers, and home care agencies, are expected to overcome these hurdles and sustain the market's growth momentum.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis by Type, Indication, Route of Administration, and Region

• By type, the home infusion therapy market segmentation includes products and services. Products consist of intravenous sets, needleless catheters, and infusion pumps.

• The market is segmented by indication, including anti-infective therapy, chemotherapy, hydration therapy, parenteral nutrition, specialty pharmaceuticals, and others, addressing a wide range of medical conditions.

• Home infusion therapy can be administered through different routes, depending on patient needs and treatment requirements. The segmentation constitutes intramuscular, subcutaneous, and epidural.

• Geographically, the market report will cover North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report

• The report highlights a significant surge in the market, primarily fueled by the rising prevalence of chronic diseases and an aging global population. These demographic shifts are increasing the demand for long-term, home-based medical treatments, driving substantial market expansion.

• Innovations in infusion devices, remote monitoring technologies, and telehealth services are pivotal in supporting the safe and effective administration of home infusion therapies. These advancements not only enhance patient safety and treatment efficacy but also contribute to the market's growth by expanding the range of therapies that can be administered at home.

• A key finding of the report is the economic benefits of home infusion therapy, both in terms of reduced healthcare costs and improved patient quality of life. The preference for receiving care in the home setting, avoiding hospital stays, and the overall convenience of home therapy are significant factors driving patient and provider adoption.

• Supportive policies and initiatives by governments worldwide to promote home healthcare services are further propelling the market forward. These initiatives aim to alleviate the burden on traditional healthcare facilities and improve patient outcomes by facilitating access to home infusion therapy.

• Despite the positive home infusion therapy market outlook, the report identifies challenges such as the need for skilled healthcare professionals to manage home therapies and the importance of patient education on home infusion practices. Addressing these challenges presents opportunities for market players to innovate and improve service delivery, ensuring the market's continued expansion.

Key Offerings of the Report

• The EMR report gives an overview of the global home infusion therapy market for the periods (2017-2023) and (2024-2032).

• The report also offers the historical (2017-2023) and forecast (2024-2032) market insights for the type, indication, route of administration, and region of the global home infusion therapy market.

• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global home infusion therapy market are Corahm LLC, Option Care Health Inc., Optum Rx, Fresenius Kabi, ICU Medical, B.Braun Melsungen AG, Baxter International, KabaFusion, Promptcare Home Infusion, InfuSystem Holdings Inc., Smith’s Medical, CareCentrix, Nipro Group, and UVA Health.

Key Highlights of the Report

About Us

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us

Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790